Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berchuck

Showing results (41-50 of 191) with videos related to

Pageof 20
Sort By:
Cancer Genetics and Cytogenetics|January 5, 2000
Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinomaM N Ahmed, K Kim, B Haddad, et al.
Journal of the Society for Gynecologic Investigation|July 1, 1994
Pathogenesis of ovarian cancersA Berchuck, A Elbendary, L Havrilesky, et al.
Obstetrics and Gynecology|December 1, 1992
Radical hysterectomy in obese womenA P Soisson, J T Soper, A Berchuck, et al.
Gynecologic Oncology|December 6, 2001
Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumorM F Vine, R B Ness, B Calingaert, et al.
Cancer|October 25, 1992
Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancerG Olt, A Berchuck, A P Soisson, et al.
Obstetrics and Gynecology|December 1, 1992
Comprehensive restaging laparotomy in women with apparent early ovarian carcinomaJ T Soper, P Johnson, V Johnson, et al.
Current Opinion in Oncology|September 1, 1993
The biology of ovarian cancerM P Boente, J Hurteau, G C Rodriguez, et al.
British Journal of Cancer|July 31, 1998
Progesterone receptor gene polymorphism and risk for breast and ovarian cancerJ M Lancaster, A Berchuck, M E Carney, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 1, 1997
Signet-ring cell carcinoma of the endometrium: a primary tumor masquerading as a metastasisE E Mooney, S J Robboy, C B Hammond, et al.
Gynecologic Oncology|December 6, 2001
Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutationsL J Havrilesky, A A Alvarez, R S Whitaker, et al.
Pageof 20

Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
Cancer Genetics and Cytogenetics|January 5, 2000
Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinomaM N Ahmed, K Kim, B Haddad, et al.
Journal of the Society for Gynecologic Investigation|July 1, 1994
Pathogenesis of ovarian cancersA Berchuck, A Elbendary, L Havrilesky, et al.
Obstetrics and Gynecology|December 1, 1992
Radical hysterectomy in obese womenA P Soisson, J T Soper, A Berchuck, et al.
Gynecologic Oncology|December 6, 2001
Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumorM F Vine, R B Ness, B Calingaert, et al.
Cancer|October 25, 1992
Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancerG Olt, A Berchuck, A P Soisson, et al.
Obstetrics and Gynecology|December 1, 1992
Comprehensive restaging laparotomy in women with apparent early ovarian carcinomaJ T Soper, P Johnson, V Johnson, et al.
Current Opinion in Oncology|September 1, 1993
The biology of ovarian cancerM P Boente, J Hurteau, G C Rodriguez, et al.
British Journal of Cancer|July 31, 1998
Progesterone receptor gene polymorphism and risk for breast and ovarian cancerJ M Lancaster, A Berchuck, M E Carney, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 1, 1997
Signet-ring cell carcinoma of the endometrium: a primary tumor masquerading as a metastasisE E Mooney, S J Robboy, C B Hammond, et al.
Gynecologic Oncology|December 6, 2001
Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutationsL J Havrilesky, A A Alvarez, R S Whitaker, et al.
Pageof 20